ACS Materials Letters,
Journal Year:
2023,
Volume and Issue:
5(4), P. 1153 - 1163
Published: March 13, 2023
Liver
fibrosis,
an
early
stage
of
cirrhosis,
with
large
number
patients
and
seriously
endangering
health,
has
no
viable
treatment
available
currently.
In
this
study,
we
choose
tetrahedral
framework
nucleic
acid
nanoparticles
as
carriers
to
deliver
the
polyphenolic
monomer
chlorogenic
injured
liver
for
first
time.
This
delivery
system
enhanced
bioavailability
stability
acid,
laying
foundation
its
antifibrotic
antioxidant
effects.
Our
findings
show
that
approach
can
reduce
fibrosis
by
down-regulating
Smad2/3
phosphorylation,
limiting
extracellular
matrix
synthesis,
substantially
improving
performance
mouse
livers
restoring
normal
function;
besides,
promote
reactive
oxygen
species
consumption
upregulating
Nrf2,
regulating
oxidative
stress
alleviating
multiorgan
damage
in
mice.
general,
created
a
nanodelivery
associated
providing
more
possibilities
clinical
application
small
molecule
drugs.
ACS Materials Letters,
Journal Year:
2023,
Volume and Issue:
5(4), P. 1153 - 1163
Published: March 13, 2023
Liver
fibrosis,
an
early
stage
of
cirrhosis,
with
large
number
patients
and
seriously
endangering
health,
has
no
viable
treatment
available
currently.
In
this
study,
we
choose
tetrahedral
framework
nucleic
acid
nanoparticles
as
carriers
to
deliver
the
polyphenolic
monomer
chlorogenic
injured
liver
for
first
time.
This
delivery
system
enhanced
bioavailability
stability
acid,
laying
foundation
its
antifibrotic
antioxidant
effects.
Our
findings
show
that
approach
can
reduce
fibrosis
by
down-regulating
Smad2/3
phosphorylation,
limiting
extracellular
matrix
synthesis,
substantially
improving
performance
mouse
livers
restoring
normal
function;
besides,
promote
reactive
oxygen
species
consumption
upregulating
Nrf2,
regulating
oxidative
stress
alleviating
multiorgan
damage
in
mice.
general,
created
a
nanodelivery
associated
providing
more
possibilities
clinical
application
small
molecule
drugs.